生技醫藥
NEW

Vertex IgA腎病藥povetacicept三期數據達標
生技醫藥
NEW

BMS口服CELMoD新藥臨床三期達標！骨髓瘤治療添新選擇？

生技醫藥
NEW

體學生技勝出！與PacBio三代定序專利戰落幕 逾2300萬美元和解  

GBI International
GBIHighlights

Next Step: Targeting Neurological Disorders and Cancer Treatment?!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Storiesbehind #BIO2023】ModernaCo-founderandAlnylamSeniorVicePresident:WitnessingthePotentialofNucleicAcidTherapyinthePandemic!NextStep:TargetingNeurologicalDisordersandCancerTreatm...
GBI International
GBIHighlights

76-year-old CSD Successfully Transitions to B2C with Innovative 'Health in Style' Products.

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】76-year-old #CSD SuccessfullyTransitionstoB2CwithInnovative'HealthinStyle'Products. CSD,aleadingbrandinTaiwanforhealthprotectionsupplieswitha76-ye...
GBI International
GBIHighlights

Taiwan Takes on Global Competition in National Genome Sequencing!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|GenomeSequencing】TaiwanTakesonGlobalCompetitioninNationalGenomeSequencing!ExpertsUrgeGovernmenttoLeadinLarge-ScaleGenomeSequencingProgram. In1992,theHumanGenomeProjectwaslaunched,a...
GBI International
GBIHighlights

Genomics Raises 4.88 Million in Seasoned Equity Offering

2023-12-01/GlobalBio & Investment
【Editor'sChoice|GenomeSequencing】UpgradedManufacturingProcessesforDomesticNucleicAcidandPeptide!GenomicsRaises4.88MillioninSeasonedEquityOffering GenomicsBioSci&Tech(4195.TWO)recentlyannounced...
GBI International
GBIHighlights

Resilience Preparedness in Taiwan's Medical Field: Another Form of Sustainability

2023-12-01/GlobalBio & Investment
ResiliencePreparednessinTaiwan'sMedicalField:AnotherFormofSustainabilityAuthor/Dr.Ray-JadeChen(ChairProfessor&ChairmanofTaipeiMedicalUniversity)Taiwanfacescomplexdisastersalongwiththehiddencon...
GBI International
GBIHighlights

Breaking the Glass Ceiling: 6 Female CEOs of Global Pharma Companies in Taiwan

2023-12-01/GlobalBio & Investment
BreakingtheGlassCeiling:6FemaleCEOsofGlobalPharmaCompaniesinTaiwan DuringtheCOVID-19pandemic,manyfemalescientistshaveplayedacrucialroleduetotheircreativityandinfluenceinaddressingvarioushealthandsocie...
GBI International
GBIHighlights

Sunny Pharmtech Aims to Submit 7 Drug License Applications This Year

2023-12-01/GlobalBio & Investment
SunnyPharmtechAimstoSubmit7DrugLicenseApplicationsThisYear,Backedby4AdvantagesforUS-JapanStrategicCollaborationOnMay2,SunnyPharmtech(6676.TWO)heldaninvestorconference,duringwhichchairmanDr.Yon-Lian Wu...
GBI International
GBIHighlights

Prix Galien Award, Nobel of Biopharmaceuticals Unveils Top Medical Products

2023-12-01/GlobalBio & Investment
PrixGalienAward,NobelofBiopharmaceuticalsUnveilsTopMedicalProducts,fromCAR-TtoCOVID-19Vaccine.TheUKheldthePrixGalienAwardceremonyafewdaysago,whichisknownasthehighesthonorinthepharmaceuticalindustry.Th...
GBI International
GBIHighlights

Dr. Frank Kung of Vivo Capital Shares US Biotech Trends

2023-12-01/GlobalBio & Investment
Dr.FrankKungofVivoCapitalSharesUSBiotechTrends:WeaknessContinuesAfter2021Peak,BigPharmaSeeksM&A,IntenseOncology&RareDiseaseCompetitionDr.FrankKung,co-founderandexecutivedirectorofVivoCapitalre...
醫療科技
共軛焦影像 3D細胞影像 YOKOGAWA 醫療科技展 CellVoyagerCQ1

橫河電機獨家「高內涵共軛焦影像分析系統」高解析3D細胞影像銷售各大藥廠、科研機構

2023-12-01/記者 彭梓涵
今(1)日，擁有百年歷史、為全球工業自動化產業供應技術與設備先驅大廠、布局生命科學30年的橫河電機集團(YOKOGAWA)，於2023醫療科技展中在單相機高內涵影像分析系統中，速度最快的雙轉盤共聚焦系統CellVoyagerCQ1，其在病理學、免疫學研究、藥物、疫苗開發都有應用的CQ1，一展出便獲國內多家新藥開發業者詢問。 雙旋轉盤共軛焦雷射設計3D細胞影像解析高 橫河電機集團新加坡亞太總部生物成...
新聞集錦
新聞集錦

超基因獲日本照沼裕NK細胞培養技術授權；成大葉明龍研發創新性軟骨細胞層片

2023-12-01/環球生技
《臺灣》超基因獲日本照沼裕NK細胞培養技術授權 今(1)日，超基因生技宣布，獲得日本免疫醫療專家照沼裕的自然殺手細胞(NK細胞)治療技術授權。照沼裕的NK細胞療法，已在日本治療超過4萬名患者。而超基因長期與照沼裕合作，繼2019年取得免疫細胞療法專利技術授權，今年再拿下培養自然殺手細胞的治療技術授權。 超基因表示，照沼裕的培養天數雖然比其他技術還多7天，但其細胞純度大增8成，細胞數量擴增超過1,5...
醫療科技
GoogleCloud 商之器 醫療科技展 醫療雲 公有雲

Google首次締結台灣醫療院所！ 助花慈打造彈性「新世代透析照護網」

2023-12-01/記者 彭梓涵
今(1)日，花蓮慈濟醫院於2023醫療科技展，宣布與GoogleCloud、商之器三方結盟，結合醫療端、加密雲端平台與微服務，為醫病建構更便利且安全的資訊通道，三方也將於明年推出「智能透析微服務」。此為Google首次與台灣醫療院所與科技廠合作，也是台灣目前唯一符合衛福部新版的「電子病歷製作及管理辦法」之公有雲平台，未來將提供花慈打造更有彈性的新世代透析照護平台，實現在不同院區都能快速建置的目標。...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務